Estrogens Down-regulate p27 in Breast Cancer Cells through Skp2 and through Nuclear Export Mediated by the ERK Pathway

This publication has 80 references indexed in Scilit:

• ErbB2/Neu-Induced, Cyclin D1-Dependent Transformation Is Accelerated in p27-Haploinsufficient Mammary Epithelial Cells but Impaired in p27-Null Cells
  Molecular and Cellular Biology, 2002
• Estrogens and cell-cycle regulation in breast cancer
  Trends in Endocrinology & Metabolism, 2001
• Cyclin-Dependent Kinase Inhibitor P27Kip1 Is Required for Mouse Mammary Gland Morphogenesis and Function
  The Journal of cell biology, 2001
• CDK inhibitors: positive and negative regulators of G1-phase progression
  Genes & Development, 1999
• Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
  Endocrine Reviews, 1999
• Relationship Between Estrogen Levels, Use of Hormone Replacement Therapy, and Breast Cancer
  JNCI Journal of the National Cancer Institute, 1998
• Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
  Nature Medicine, 1997
• Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein
  Oncogene, 1997
• Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status
  British Journal of Cancer, 1996
• Inhibitors of mammalian G1 cyclin-dependent kinases.
  Genes & Development, 1995